In addition, YAP-PRDM4 interaction-mediated ITGB2 expression was also found to be required for cell invasion in metastatic prostate cancer [55], while YAP-induced expression of ARHGAP29 could promote tumor cell migration by suppressing the RhoA-LIMK-cofilin pathway [56]. The gene discussed is YAP1; the disease is metastatic prostate carcinoma.